Contec Medical Valuation

300869 Stock   15.48  0.19  1.24%   
At this time, the firm appears to be overvalued. Contec Medical Systems shows a prevailing Real Value of USD13.07 per share. The current price of the firm is USD15.48. Our model approximates the value of Contec Medical Systems from analyzing the firm fundamentals such as Profit Margin of (0.04) %, return on equity of -0.0097, and Current Valuation of 5.74 B as well as examining its technical indicators and probability of bankruptcy.
Price Book
3.1775
Enterprise Value
5.7 B
Enterprise Value Ebitda
127.8144
Price Sales
13.4177
Enterprise Value Revenue
12.3812
Overvalued
Today
15.48
Please note that Contec Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Contec Medical Systems is based on 3 months time horizon. Increasing Contec Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Contec Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Contec Stock. However, Contec Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  15.48 Real  13.07 Hype  15.87 Naive  15.16
The real value of Contec Stock, also known as its intrinsic value, is the underlying worth of Contec Medical Systems Company, which is reflected in its stock price. It is based on Contec Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Contec Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
13.07
Real Value
16.89
Upside
Estimating the potential upside or downside of Contec Medical Systems helps investors to forecast how Contec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Contec Medical more accurately as focusing exclusively on Contec Medical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
15.0715.2815.49
Details
Hype
Prediction
LowEstimatedHigh
12.0515.8719.69
Details
Naive
Forecast
LowNext ValueHigh
11.3415.1618.98
Details

Contec Medical Cash

422.74 Million

Contec Medical Total Value Analysis

Contec Medical Systems is presently forecasted to have takeover price of 5.74 B with market capitalization of 6.22 B, debt of 1.05 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Contec Medical fundamentals before making investing decisions based on enterprise value of the company

Contec Medical Investor Information

About 64.0% of the company shares are owned by insiders or employees . The book value of Contec Medical was presently reported as 4.81. The company recorded a loss per share of 0.05. Contec Medical Systems last dividend was issued on the 29th of May 2024. Based on the analysis of Contec Medical's profitability, liquidity, and operating efficiency, Contec Medical Systems is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities146.9 M288.7 M
Way Down
Slightly volatile
Operating Income194 M109.1 M
Way Up
Slightly volatile

Contec Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Contec Medical has an asset utilization ratio of 22.79 percent. This suggests that the Company is making USD0.23 for each dollar of assets. An increasing asset utilization means that Contec Medical Systems is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

Contec Medical Ownership Allocation

Contec Medical holds a total of 401.8 Million outstanding shares. Contec Medical Systems shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.21 percent of Contec Medical Systems outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Contec Medical Profitability Analysis

The company reported the revenue of 734.05 M. Net Income was 165.77 M with profit before overhead, payroll, taxes, and interest of 330 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Contec Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Contec Medical and how it compares across the competition.

About Contec Medical Valuation

The stock valuation mechanism determines Contec Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Contec Medical. We calculate exposure to Contec Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Contec Medical's related companies.
Last ReportedProjected for Next Year
Gross Profit404.7 M317.7 M

Contec Medical Quarterly Retained Earnings

978.48 Million

Complementary Tools for Contec Stock analysis

When running Contec Medical's price analysis, check to measure Contec Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Contec Medical is operating at the current time. Most of Contec Medical's value examination focuses on studying past and present price action to predict the probability of Contec Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Contec Medical's price. Additionally, you may evaluate how the addition of Contec Medical to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets